Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Mental Health

Date Submitted: Feb 22, 2022
Date Accepted: Sep 6, 2022

The final, peer-reviewed published version of this preprint can be found here:

Positive Affective Recovery in Daily Life as a Momentary Mechanism Across Subclinical and Clinical Stages of Mental Disorder: Experience Sampling Study

Ader L, Schick A, Simons C, Delespaul P, Myin-Germeys I, Vaessen T, Reininghaus U

Positive Affective Recovery in Daily Life as a Momentary Mechanism Across Subclinical and Clinical Stages of Mental Disorder: Experience Sampling Study

JMIR Ment Health 2022;9(11):e37394

DOI: 10.2196/37394

PMID: 36416883

PMCID: 9730210

Positive affective recovery in daily life as a momentary mechanism across subclinical and clinical stages of mental disorder: Experience Sampling Study

  • Leonie Ader; 
  • Anita Schick; 
  • Claudia Simons; 
  • Philippe Delespaul; 
  • Inez Myin-Germeys; 
  • Thomas Vaessen; 
  • Ulrich Reininghaus

ABSTRACT

Background:

Identifying momentary risk and protective mechanisms may enhance our understanding and treatment of mental disorders. Affective stress reactivity is one mechanism that has been reported to be altered in individuals with early and later stages of mental disorder. Additionally, initial evidence suggests individuals with early and enduring psychosis may have an extended recovery period of negative affect in response to daily stressors (i.e., a longer duration until affect reaches baseline levels after stress), but evidence on positive affective recovery as a putative protective mechanism remains limited.

Objective:

This study aimed to investigate trajectories of positive affect in response to stress across the continuum of mental disorder in a transdiagnostic sample.

Methods:

Using the Experience Sampling Method, minor activity-, event-, and overall stress and positive affect were assessed 10 times a day, with time points approximately 90 minutes apart on six consecutive days in a pooled data set including 367 individuals with mental disorder, 217 individuals at risk for a severe mental disorder, and 227 controls. Multilevel analysis and linear contrasts were used to investigate trajectories of positive affect within and between groups.

Results:

Baseline positive affect differed across groups and we observed stress reactivity in positive affect within each group. We found evidence for positive affective recovery after reporting activity- or overall stress within each group. While controls recovered to baseline positive affect about 90 minutes after stress, patients and at-risk individuals required about 180 minutes to recover. However, between-group differences in the affective recovery period fell short of significance.

Conclusions:

The results provide first evidence that positive affective recovery may be relevant within transdiagnostic subclinical and clinical stages of mental disorder suggesting it may be a potential target for mobile health interventions fostering resilience in daily life.


 Citation

Please cite as:

Ader L, Schick A, Simons C, Delespaul P, Myin-Germeys I, Vaessen T, Reininghaus U

Positive Affective Recovery in Daily Life as a Momentary Mechanism Across Subclinical and Clinical Stages of Mental Disorder: Experience Sampling Study

JMIR Ment Health 2022;9(11):e37394

DOI: 10.2196/37394

PMID: 36416883

PMCID: 9730210

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.

Advertisement